Venus Remedies Limited

VENUSREM

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 2026219

    Quarter₹ croreYoY
    Sept 2024167-1.9%
    Dec 2024173+31.5%
    Mar 2025194+10.8%
    Jun 2025132+24.6%
    Sept 2025193+15.3%
    Dec 2025180+4.3%
    Mar 2026259+33.5%
    Jun 2026179+35.6%
    Sept 2026219+13.6%
  • ₹ crore

    Sept 20260.40

    Quarter₹ crore
    Sept 202411
    Dec 20242
    Mar 20257
    Jun 20258
    Sept 20252
    Dec 20252
    Mar 20265
    Jun 20263
    Sept 20260.40
  • ₹ crore

    Sept 2026219

    Quarter₹ crore
    Sept 2024178
    Dec 2024174
    Mar 2025201
    Jun 2025140
    Sept 2025194
    Dec 2025182
    Mar 2026264
    Jun 2026181
    Sept 2026219
  • Cost structure
  • ₹ crore

    Sept 202626

    Quarter₹ crore
    Sept 202419
    Dec 202417
    Mar 202519
    Jun 202519
    Sept 202522
    Dec 202520
    Mar 202624
    Jun 202623
    Sept 202626
  • ₹ crore

    Sept 2026182

    Quarter₹ crore
    Sept 2024163
    Dec 2024155
    Mar 2025176
    Jun 2025125
    Sept 2025169
    Dec 2025150
    Mar 2026206
    Jun 2026149
    Sept 2026182
  • Exceptional items and tax
  • ₹ crore

    Sept 202637

    Quarter₹ crore
    Sept 202415
    Dec 202429
    Mar 202525
    Jun 202515
    Sept 202526
    Dec 202533
    Mar 202658
    Jun 202633
    Sept 202637
  • ₹ crore

    Sept 20268

    Quarter₹ crore
    Sept 20246
    Dec 20245
    Mar 20257
    Jun 20253
    Sept 20256
    Dec 20258
    Mar 202614
    Jun 20267
    Sept 20268
  • Profit
  • ₹ crore

    Sept 202629

    Quarter₹ croreYoY
    Sept 20249+69.9%
    Dec 202424+194.0%
    Mar 202515+18.2%
    Jun 202512+162.7%
    Sept 202519+107.8%
    Dec 202525+3.5%
    Mar 202643+193.9%
    Jun 202626+118.4%
    Sept 202629+50.5%
  • Per share
  • ₹ per share

    Sept 202621.66

    Quarter₹ per share
    Sept 20246.92
    Dec 202418.02
    Mar 202511.07
    Jun 20258.75
    Sept 202514.40
    Dec 202518.64
    Mar 202632.51
    Jun 202619.10
    Sept 202621.66
  • Leverage
  • Debt to equity

    times

    Mar 20250.00x

    Quartertimes
    Sept 2024—
    Dec 2024—
    Mar 20250.00x
    Jun 2025—
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
    Sept 2026—
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
167173194132193180259179219
Revenue YoY-1.9%+31.5%+10.8%+24.6%+15.3%+4.3%+33.5%+35.6%+13.6%
1127822530.40
178174201140194182264181219
Cost structure
191719192220242326
163155176125169150206149182
Exceptional items and tax
152925152633583337
6573681478
Profit
92415121925432629
Net profit YoY+69.9%+194.0%+18.2%+162.7%+107.8%+3.5%+193.9%+118.4%+50.5%
Per share
6.9218.0211.078.7514.4018.6432.5119.1021.66
Leverage
Debt to equity——0.00x——————

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.